Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Ribosomal protein L36a pseudogene 14 (RPL36AP14)** is a *pseudogene*, meaning it is a genomic DNA sequence similar to a functional gene but generally non-coding and non-functional. RPL36AP14 is one of many processed pseudogenes related to ribosomal protein L36a (RPL36A); it does not encode a functional protein and has no established biological activity or disease association. Pseudogenes like RPL36AP14 are typically the result of gene duplication or retrotransposition events and, while related to the ribosomal protein gene family, do *not* perform known molecular or physiological functions[1][3][7][10]. **Notes:** - RPL36AP14 is not a functional protein, drug target, or biomarker. - Any mention of disease association, drug interaction, or mechanism of action is for the parent gene (RPL36A) or related ribosomal proteins, not this pseudogene. - If you intended to research the functional ribosomal protein L36a, refer to the gene symbol **RPL36A** or **RPL36AL** instead[3][7][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L36a pseudogene 14 (RPL36AP14).